Silexion Therapeutics Corp SLXN shares are moving higher on Wednesday after the company reported that Guangzhou Sino-Israel bio-industry investment fund holds a stake in the company.
The Details: According to a FormSC13D filed with the Securities and Exchange Commission, Guangzhou Sino-Israel holds a 13.8% stake in Silexion.
The company’s 13.8% stake in the company equates to 1,987,082 shares.
Silexion is trading on higher-than-normal volume at 171.05 million, compared to its average session volume of 2.73 million over the past 100 days, per data from Benzinga Pro.
How To Buy Silexion Shares
By now you're likely curious about how to participate in the market for Silexion Therapeutics SLXN – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, = can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of Silexion Therapeutics, which is trading at $0.32 as of publishing time, $100 would buy you 312.5 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
Related Link: Nvidia, Microstrategy, Apollo Global Management, Joby Aviation, And Tesla: Why These 5 Stocks Are On Investors’ Radars Today
SLXN Price Action: At the time of writing, Silexion shares are moving 44.1% higher at 32 cents, according to data from Benzinga Pro.
Image: PublicDomainPictures from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.